Showing results 1 to 3 of 3
Title | Author(s) | Issue Date | |
---|---|---|---|
The activity of mTOR inhibitor RAD001 (everolimus) in nasopharyngeal carcinoma and cisplatin-resistant cell lines Journal:Investigational New Drugs | 2010 | ||
Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell lines Journal:Investigational New Drugs | 2013 | ||
Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models Journal:Cancer Letters | 2014 |